Category Archives: EP and UK Practice

From SLW International: Info on the Unitary Patent and the Unified Patent Court

Guest contribution from SLW International: A short paper with information on the Unitary Patent and the Unified Patent Court can be found here.

Posted in EP and UK Practice, Int'l Practice and Policy, Non-U.S. Practice, Uncategorized | Tagged , , | Leave a comment

Interesting Developments at the EPO

Guest post from Rigel Menard. There are changes at the EPO coming that require the specification to better reflect the allowed claims. In applications in which multiple inventions are disclosed, the new rules seem to be requiring editing the specification … Continue reading

Posted in EP and UK Practice | Tagged | Leave a comment

Regeneron v. Kymab – “Sufficiency” and Enablement in the U.K.

Guest post from Paul Cole. Regeneron Pharmaceuticals Inc v Kymab Ltd. [2020] UKSC 27 related to infringement of EP-B-1,360,287 and its divisional EP-B-2264123. The 287 parent related to a method of modifying an endogenous immunoglobulin variable region gene locus in … Continue reading

Posted in EP and UK Practice | Tagged | Leave a comment

EPO – New Guidance On Added Subject Matter

A guest post from Paul Cole. Readers will be aware that added subject matter issues have for a long time been a thorny issue for EPO Examination practice. On 7 February 2014 a symposium on EPO practice regarding Art. 123(2) … Continue reading

Posted in EP and UK Practice | Tagged , , , , , | Leave a comment